Literature DB >> 34245863

S1P signaling, its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer.

Real Sumayya Abdul Sattar1, Mamta P Sumi1, Arun Kumar1, Abhay Kumar Sharma1, Ejaj Ahmad1, Asgar Ali2, Bhawna Mahajan3, Sundeep Singh Saluja4.   

Abstract

Sphingosine-1-Phosphate (S1P) plays an important role in normal physiology, inflammation, initiation and progression of cancer. Deregulation of S1P signaling causes aberrant proliferation, affects survival, leads to angiogenesis and metastasis. Sphingolipid rheostat is crucial for cellular homeostasis. Discrepancy in sphingolipid metabolism is linked to cancer and drug insensitivity. Owing to these diverse functions and being a potent mediator of tumor growth, S1P signaling might be a suitable candidate for anti-tumor therapy or combination therapy. In this review, with a focus on colorectal cancer we have summarized the interacting partners of S1P signaling pathway, its therapeutic approaches along with the contribution of S1P signaling to various cancer hallmarks.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRC; Cancer hallmarks; Deregulation; S1P signaling; Therapy

Mesh:

Substances:

Year:  2021        PMID: 34245863     DOI: 10.1016/j.cellsig.2021.110080

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

1.  Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids.

Authors:  Anat Galor; Victor Sanchez; Andrew Jensen; Madeline Burton; Kenneth Maus; Daniel Stephenson; Charles Chalfant; Nawajes Mandal
Journal:  Ocul Surf       Date:  2021-11-30       Impact factor: 6.268

Review 2.  The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance.

Authors:  Run-Ze Li; Xuan-Run Wang; Jian Wang; Chun Xie; Xing-Xia Wang; Hu-Dan Pan; Wei-Yu Meng; Tu-Liang Liang; Jia-Xin Li; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Elaine Lai-Han Leung
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

3.  Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.

Authors:  Makoto Kurano; Eri Sakai; Yutaka Yatomi
Journal:  Cancer Med       Date:  2022-03-22       Impact factor: 4.711

4.  Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors.

Authors:  Shuangshuang Geng; Haijiao Chen; Yan Li; Ying Li; Jingxiang Pang; Feipeng Zhang; Zhiqiang Qu; Mengjun Li; Na Liu; Qingqiang Yao; Yanling Mu; Bo Liu
Journal:  Molecules       Date:  2022-03-21       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.